Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Natco Pharma gains on receiving Establishment Inspection Report for Kothur facility

17-Aug2016

Natco Pharma gains on receiving Establishment Inspection Report for Kothur facility

Natco Pharma is currently trading at Rs. 645.30, up by 5.00 points or 0.78% from its previous closing of Rs 640.30 on the BSE.

The scrip opened at Rs. 649.00 and has touched a high and low of Rs. 649.00 and Rs. 640.60 respectively. So far 5769 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 654.00 on 16-Aug-2016 and a 52 week low of Rs. 382.20 on 24-Aug-2015.

Last one week high and low of the scrip stood at Rs. 654.00 and Rs. 619.00 respectively. The current market cap of the company is Rs. 11212.47 crore.

The promoters holding in the company stood at 51.28%, while Institutions and Non-Institutions held 26.01% and 22.70% respectively.

Natco Pharma has received successful Establishment Inspection Report (EIR) during the period February 29 to March 7, 2016 from the U.S. Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility in Kothur Village, Mahaboob Nagar District, India. The Kothur facility predominantly caters to regulated international markets, including USA. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.


Related News

View all news

Jammu & Kashmir Bank trades higher on the bourses

The Jammu & Kashmir Bank is currently trading at Rs. 42.65, up by 0.45 points or 1.07% from its previous closing of Rs. 42.20 on the BSE.The scrip opened at Rs. 42.25 and has touched a high and......

IndiGo trades in green on the BSE

Interglobe Aviation is currently trading at Rs. 843.65, up by 7.30 points or 0.87% from its previous closing of Rs. 836.35 on the BSE.The scrip opened at Rs. 848.10 and has touched a high and low of Rs.......

Mphasis slips despite reporting 37% rise in Q2 consolidated net profit

Mphasis is currently trading at Rs. 1070.00, down by 53.10 points or 4.73% from its previous closing of Rs. 1123.10 on the BSE.The scrip opened at Rs. 1107.00 and has touched a high and low of Rs. 1119.90......

Top News

View all news

IRB Infrastructure's arm achieves financial closure for Vadodara-Mumbai Expressway project

IRB Infrastructure Developers' Wholly-owned Subsidiary (SPV) -- VK1 Expressway has achieved financial closure for the project of construction of eight lane Vadodara Kim Expressway from Km 355.00 to Km......

Havells India reports 4% rise in Q2 net profit

Havells India has reported results for second quarter ended September 30, 2018.The company has reported 4.44% rise in its net profit at Rs 178.62 crore for the quarter under review as compared to Rs 171.02......

Mphasis reports 37% rise in Q2 consolidated net profit

Mphasis has reported results for second quarter ended September 30, 2018.The company has reported a rise of 9.42% in its net profit of Rs 188.94 crore for the quarter under review as compared to Rs 172.67......